Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.
D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives; D019468:Disease Management; D006801:Humans; D008190:Lyases / Q000037:antagonists & inhibitors*; D008303:Malignant Carcinoid Syndrome / Q000628:therapy*; D008750:Methyldopa; D010649:Phenylalanine
D010649:Phenylalanine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D008190:Lyases
DESMOLASES/antagonists; DOPA/related compounds; MALIGNANT CARCINOID SYNDROME/therapy